Skip to main content

Definitive Healthcare Corp.

corporate_fare Company Profile

Definitive Healthcare Corp.

DH·NASDAQ·Technology·CIK 0001861795

Definitive Healthcare is a leading provider of healthcare data and analytics, transforming data, analytics, and expertise into healthcare commercial intelligence. The company offers accurate, comprehensive information on healthcare providers and their activities, along with claims and consumer analytics built from modeled data on millions of unique consumers. This information is delivered through its software-as-a-service ("SaaS") platform and products. As of December 31, 2025, Definitive Healthcare served approximately 2,330 customers, defined as companies with one or more active paid subscriptions. The company serves three primary end markets: Life Sciences, Provider, and Diversified. Life Sciences customers include biopharmaceutical and medical device companies. Providers consist of hospitals, health systems, and other care delivery organizations. Diversified customers encompass healthcare information technology companies and other organizations within the healthcare market, such as staffing firms, commercial real estate firms, financial institutions, and marketing and advertising agencies. The company's data supports various functional groups within these organizations, including sales, marketing, clinical research, product development, strategy, talent acquisition, and physician network management. Customers access data products on a subscription basis, and substantially all revenue is generated from subscription fees. Definitive Healthcare was founded in 2011 and incorporated as Definitive Healthcare Corp. in May 2021. Its corporate headquarters are located in Framingham, MA.

Definitive Healthcare Corp. (NASDAQ:DH) is a publicly traded company in the Technology sector. Wiseek has independently scored 18 items for DH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for DH spans 8-K, SCHEDULE 13D/A, SCHEDULE 13D, 10-Q.

Recent high-impact activity:

  • Definitive Healthcare Q3 Revenue $54.7M, Down 9%; Profit Beats, No Guidance on Advent Deal
  • Advent Signs Confidentiality Agreement with Definitive Healthcare, Advancing Take-Private Talks
  • TRA Holders Waive Early Termination Payment, Clearing Path for Advent Take-Private
  • Advent International Offers $1.02/Share to Take Definitive Healthcare Private
  • Founder Krantz Holds 17.6% Stake, Weighs Rollover in Advent's $1.02/Share Buyout

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$241.52M
Net Income
-$138.93M
Diluted EPS
-$1.30
Op. Cash Flow
$53.78M
Free Cash Flow
$37.06M
Gross Profit
$183.28M
Operating Income
-$224.27M
Cash & Equivalents
$163.63M
Total Debt
$164.84M
Debt / Equity
0.43×
Net Margin
-57.5%
Shares Outstanding
106.65M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-076782

Short Interest & Short Volume

3.82 days to cover

FINRA reported short interest of 1,617,835 shares in DH as of the October 30, 2026 settlement, a 16.0% decrease from the prior period — about 3.8 days to cover at its recent average daily volume. On November 20, 2026, 37.2% of DH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,617,835 shares as of October 30, 2026
Change vs prior period▼ 16.0%
Days to cover3.82 at avg daily volume of 423,363
Daily short volume (FINRA facilities)37.2% of 188,311 shares on November 20, 2026
5-day average short volume38.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with D →
$1.22 +1.67% today
52-week range · as of 2026-11-05 $0.6103 – $3
Market cap
$174.31M
Volume
390K (0.9× avg)
3-mo avg 423.5K
Live data · 2026-11-22 11:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DH - Latest Insights

DH
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Updated Nov 5, 4:59 PM ET — Q3 revenue fell 9% yr/yr to $54.65 mln, slightly beating the $54.59 mln consensus estimate from 5 analysts.
Price at Filing: $1.13
Real-time Price: $1.22 info
Change: +$0.090 (+8%) info
Market Cap: $174.31M info
DH
Oct 01, 2026, 8:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.9361
Real-time Price: $1.22 info
Change: +$0.2839 (+30%) info
Market Cap: $174.31M info
DH
Sep 09, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $1.22 info
Change: +$0.190 (+18%) info
Market Cap: $174.31M info
DH
Sep 02, 2026, 9:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $1.22 info
Change: +$0.170 (+16%) info
Market Cap: $174.31M info
DH
Sep 02, 2026, 8:40 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $1.22 info
Change: +$0.210 (+21%) info
Market Cap: $174.31M info
DH
Sep 02, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $1.22 info
Change: +$0.270 (+28%) info
Market Cap: $174.31M info
DH
Sep 02, 2026, 8:30 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $0.890
Real-time Price: $1.22 info
Change: +$0.330 (+37%) info
Market Cap: $174.31M info
DH
Aug 10, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.6985
Real-time Price: $1.22 info
Change: +$0.5215 (+75%) info
Market Cap: $174.31M info
DH
Aug 10, 2026, 4:22 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.6985
Real-time Price: $1.22 info
Change: +$0.5215 (+75%) info
Market Cap: $174.31M info
DH
Aug 10, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6985
Real-time Price: $1.22 info
Change: +$0.5215 (+75%) info
Market Cap: $174.31M info
DH
Jun 24, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.760
Real-time Price: $1.22 info
Change: +$0.460 (+61%) info
Market Cap: $174.31M info
DH
Jun 05, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.897
Real-time Price: $1.22 info
Change: +$0.323 (+36%) info
Market Cap: $174.31M info
DH
May 07, 2026, 4:23 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.949
Real-time Price: $1.22 info
Change: +$0.271 (+29%) info
Market Cap: $174.31M info
DH
May 07, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.949
Real-time Price: $1.22 info
Change: +$0.271 (+29%) info
Market Cap: $174.31M info
DH
Apr 23, 2026, 4:10 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $0.9998
Real-time Price: $1.22 info
Change: +$0.2202 (+22%) info
Market Cap: $174.31M info
DH
Apr 23, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.03
Real-time Price: $1.22 info
Change: +$0.190 (+18%) info
Market Cap: $174.31M info
DH
Feb 26, 2026, 4:21 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $1.30
Real-time Price: $1.22 info
Change: -$0.080 (-6%) info
Market Cap: $174.31M info
DH
Feb 26, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.31
Real-time Price: $1.22 info
Change: -$0.0882 (-7%) info
Market Cap: $174.31M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets